Introduction
============

Structural pathologies in the uterine cavity are well-established as factors associated with infertility. Intrauterine lesions (IULs) have been linked generally to fertility reduction and more specifically to implantation failure and miscarriage.[@b1-ijwh-3-353] The most commonly suspected intrauterine pathologies involved in infertility include endometrial polyps, shown to affect 9.4%--39.4% of infertile women,[@b2-ijwh-3-353],[@b3-ijwh-3-353] submucosal fibroids, adhesions, and uterine malformations. Efficient detection and adequate management of lesions is imperative in infertile women so optimal infertility treatment can proceed.

Hysterosalpingography (HSG) is a radiological modality most commonly used for the assessment of the uterine cavity. Although HSG is generally accepted as the initial diagnostic procedure performed in infertile women, several disadvantages are inherent to the technique,[@b4-ijwh-3-353] including exposure to ionizing radiation and the injection of radio-opaque material. Sonohysterography (SHG), described in detail elsewhere,[@b5-ijwh-3-353] has rapidly become a popular tool for the diagnosis of intrauterine pathologies.[@b6-ijwh-3-353] In spite of its unequivocal advantages, such as low cost and the fact that patients are not subjected to ionizing radiation, the procedure is more time consuming than HSG and can lead to vasovagal shock in certain patients.[@b5-ijwh-3-353] SHG has yet to be presented as an alternative gold standard for investigating the uterine cavity.[@b6-ijwh-3-353]

Hysteroscopy, however, is considered a gold-standard technique for uterine cavity examination, since it allows direct visualization of potential lesions and can be paired with biopsy if necessary. Nevertheless, this procedure is invasive and often requires anesthesia and specialized equipment (ie, a hysteroscope). Moreover, hysteroscopy is more costly than HSG or SHG and does not provide information about the external morphology of the organ,[@b7-ijwh-3-353] myometrium, or adnexa.[@b8-ijwh-3-353]

Transvaginal sonography (TVS) is a simple, painless, and cost-effective examination that is capable of providing accurate information about IULs and is not associated with adverse pregnancy outcomes.[@b9-ijwh-3-353],[@b10-ijwh-3-353] However, studies of the diagnostic accuracy of TVS have produced conflicting results.[@b10-ijwh-3-353]--[@b16-ijwh-3-353] Since specific disorders of the intrauterine cavity are most efficiently diagnosed at different phases of the menstrual cycle,[@b17-ijwh-3-353] the conflicting results of previous reports may be at least partially due to this factor, in addition to interobserver bias. Uterine lesions could be the reason for infertility in 10% to 15% of cases.[@b5-ijwh-3-353]

Identification of an efficient, accessible, painless, and reliable tool in the diagnosis of IULs is of great importance in the care of infertile patients, and the aim of the present study was to evaluate the diagnostic accuracy of TVS in the detection of intrauterine abnormalities during different phases of the menstrual cycle in infertile women. TVS was compared with SHG and hysteroscopy, which represent the gold standard in the evaluation of IULs.

Patients and methods
====================

The study protocol was approved by the Institutional Review Board and Ethics Committee of the University of Medical Sciences in Urmia, Iran. Written informed consent was obtained from all participants in the presence of a witness. All patients were free to withdraw from the study at any time and for any reason.

Five hundred and six infertile females attending the Center for Infertility Treatment and Research of Shahid Mottahari Hospital in Urmia, Iran, were consecutively enrolled in the study between September 2008 and February 2009. Patients' infertility was defined as a failure to conceive after 1 year of unprotected intercourse.[@b5-ijwh-3-353] This center is the only infertility clinic in the West Azerbaijan province of Iran and all infertile patients in the area are referred exclusively to this center.

All participants initially underwent routine infertility work-up consisting of hormone testing (luteinizing hormone, follicle-stimulating hormone, prolactin, thyroid-stimulating hormone, estradiol), hysterosalpingography, and their partner's semen was analyzed. In addition, the couple's etiology of infertility and the regularity of the woman's menstrual cycle were noted. Further participation in the study was dependent on the detection of IULs with HSG. Patients with no detectable IULs attempted assisted reproduction (AR) consisting of either intracytoplasmic sperm injection or intrauterine insemination. Women attempting AR and women with detected lesions underwent TVS every 3--4 days starting from the first day of their menstrual cycle. In women attempting AR, TVS was used to evaluate the intrauterine cavity and to monitor follicular development and ovulation. In total, each patient underwent TVS six times. Phases of the menstrual cycle during which the lesion was visible or invisible were recorded. If an intrauterine pathology was detected with TVS, the finding was explained to participants and those patients were then candidates to undergo SHG.

SHG was performed during the follicular phase, 2 days after the last menstrual period. Before the procedure was performed, all patients were examined by a gynecologist and by TVS to exclude the presence of fluid in the cul-de-sac (retrounterine pouch). The patients were also asked to refrain from intercourse before the examination. Pregnant patients, patients with sexually transmitted diseases, with fluid in the cul-de-sac, or with abnormal uterine bleeding were excluded from the study. If an IUL was confirmed with SHG, the patient underwent further hysteroscopy during which the lesion was resected.

TVS was performed by a physician with 10 years' experience (MH); hysteroscopy was performed by another reproduction specialist with 12 years' experience (FB); a radiologist with 20 years' experience, who had no knowledge of the ultrasonographic results, performed SHG.

Results
=======

Twelve of the 506 patients had IULs detectable by HSG and were referred for further treatment. These patients also underwent TVS every 3--4 days and TVS was able to detect the lesions in all cases. The remaining 492 patients attempted AR and also underwent TVS with the same frequency as patients with detected lesions, a total of six times. Of those, 29 had TVS-detectable IULs, yielding a total of 41 women (12 + 29, 8%) with detectable IULs in the study.

The ages of the 41 women ranged from 19 to 42 years (mean age 31 years). Thirty-one (75%) suffered from primary and ten (25%) from secondary infertility. In 19 (46%) women, the infertility etiology was unknown; in twelve (29%) it was caused by a male factor, in five (12%) by anovulation and in another five by tubal factor. Thirty-two (78%) had regular menses and nine (22%) irregular.

The 41 patients with detectable IULs underwent SHG, which confirmed the lesions in 39 (95%) patients, and two (5%) showed false positive results (which were possibly due to blood clots). Of the 41 with detectable IULs, 39 had a submucosal myoma and 35 had an intrauterine polyp (38 single and only one double lesion). There were 35 polyps and four submucosal leiomyomas. Lesions were mostly 5--10 mm in size but there were some up to 20 mm.

As a control, women with no detectable lesion on TVS were offered the option of undergoing SHG. Of 465 patients, 122 consented and two of those were shown to have delicate adhesions previously undetected by TVS.

Correlation between menstrual cycle and detection of IULs
---------------------------------------------------------

All 39 SHG-confirmed lesions were detectable by TVS between days 16 and 19 of the menstrual cycle. Of those, nine were not detectable between days 20 and 24 and 20 were undetectable between days 25 and 30, indicating that those lesions could not be visualized during the luteal phase of the cycle.

Nine of the 39 lesions were \<1 cm in size and 30 were ≥1 cm, as shown by hysteroscopy. Lesions of \<1 cm were detected by TVS during the ovulatory and luteal phases (days 16--19) of the cycle and none of those were detectable during the follicular phase (days 1--12). Only three of the lesions were detectable in the middle to late luteal phase (days 20--30).

All lesions ≥1 cm were detectable during the ovulatory and early luteal phases. Of those, 26 (67%) were visualized during the follicular phase and 27 (69%) were detected during the middle to late luteal phase. In summary, all 39 lesions were detected during the early luteal and ovulatory phases.

According to these data, the highest sensitivity, specific-ity, positive predictive value (PPV), and negative predictive value (NPV) of TVS were at the beginning of the luteal phase (days 16--19), confirming this time segment as optimal for performing TVS ([Table 1](#t1-ijwh-3-353){ref-type="table"}).

Discussion
==========

IULs are a relatively common finding in women of reproductive age,[@b1-ijwh-3-353],[@b18-ijwh-3-353] and their occurrence is even more frequent in women who have trouble conceiving. As far as the authors are aware, this is the first study that has attempted to evaluate the diagnostic accuracy of TVS in diagnosing intrauterine pathologies in infertile women during different phases of their menstrual cycle.

The main finding of this study is that the efficiency of TVS is highly affected by the phase of the ovulatory cycle during which the procedure is performed. This was especially apparent in the diagnosis of lesions of \<1 cm, of which only one-third could be detected in the middle to late luteal phase, while all lesions were detectable in the ovulatory phase and at the beginning of the luteal phase. During the these parts of these two phases, all lesions ≥1 cm were detected, while only about 67%--69% of those were detected in other phases of the cycle. This indicates that the ovulatory phase and the beginning of the luteal phase are the optimal phases of the cycle to perform TVS to detect intrauterine pathologies. TVS sensitivity, specificity, PPV, and NPV during this phase (days 16--19), in comparison with SHG, reached 95%, 98%, 95.1%, and 98%, respectively ([Table 2](#t2-ijwh-3-353){ref-type="table"}).

There are discordant reports of the sensitivity and specific-ity of TVS in the diagnosis of intrauterine pathologies[@b6-ijwh-3-353],[@b13-ijwh-3-353],[@b15-ijwh-3-353],[@b19-ijwh-3-353]--[@b23-ijwh-3-353] ([Table 3](#t3-ijwh-3-353){ref-type="table"}, [Figure 1](#f1-ijwh-3-353){ref-type="fig"}), while there are no such major discrepancies in the evaluation of SHG or hysteroscopy. Since the authors' results clearly indicate that menstrual cycle phase may be an important factor in the efficiency of TVS, previous conflicting reports may be due to the fact that TVS is performed on various days of the ovulatory cycle, while hys-teroscopy and SHG are predominantly performed during the early follicular phase because menstrual bleeding decreases visualization of the uterine cavity and because they cannot be performed during the luteal phase since those procedures may interfere with ongoing pregnancy and lead to miscarriage or ectopic pregnancy. TVS, however, can be performed at any time without increased danger to the patient or to a potential embryo.

Since the sensitivity, specificity, PPV, and NPV of HSG compared with SHG was 29%, 98%, 100%, and 78%, respectively, it suggests that HSG is a very limited method for the diagnosis of IULs, as previously reported.[@b8-ijwh-3-353] If fallopian tubes patency does not need to be assessed, the authors suggest TVS as the first method to assess the intrauterine cavity, although it may not be able to detect smaller pathological structures.

Delicate adhesions in two patients were not detected by TVS but were shown by SHG. However, using TVS with saline infusion has been shown to reach the sensitivity of hysteroscopy in the diagnosis of IULs.[@b23-ijwh-3-353] If hysteroscopy is inaccessible, performing TVS at the ovulatory or early luteal phase, in combination with SHG, may be an optimal approach for evaluating the integrity of intrauterine cavity. Unlike hysteroscopy, SHG provides additional information about the adnexa and the combined techniques provide invaluable data about the reproductive system of infertile females.

In conclusion, the data indicate that the accuracy of TVS in the diagnosis of IULs is highly dependent on the ovulatory cycle phase and, if performed during the early luteal phase, its specificity reaches 98%. The authors' results indicate that the optimal time to perform TVS to detect intrauterine pathologies is during the ovulatory or early luteal phases. All lesions, irrespective of their size, were detected during this cycle phase (ovulatory or early luteal phases, days 16--19).

In addition, if confirmed by further studies, TVS accompanied by SHG, when performed at the optimal ovulatory cycle phase, may represent a future cost-effective alternative to hysteroscopy in the evaluation of the intrauterine cavity.
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![Heat map of outcomes of various studies assessing transvaginal sonography (complementary to [Table 3](#t3-ijwh-3-353){ref-type="table"}\*).\
**Note:** \*Rows 1--10 correlate with studies 1--10 in [Table 3](#t3-ijwh-3-353){ref-type="table"}.\
**Abbreviations:** PPV, positive predictive value; NPV, negative predictive value.](ijwh-3-353f1){#f1-ijwh-3-353}

###### 

Sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) of transvaginal sonography on different days of the menstrual cycle

  **Day of cycle**   **N**   **Yes[\*](#tfn2-ijwh-3-353){ref-type="table-fn"}**   **Sensitivity**   **Specificity**   **PPV**   **NPV**
  ------------------ ------- ---------------------------------------------------- ----------------- ----------------- --------- ---------
  1--4               495     11                                                   28.2%             100%              100%      94%
  5--8               490     16                                                   41.2%             100%              100%      95%
  9--12              480     26                                                   66.6%             100%              100%      97%
  13--15             471     35                                                   89.7%             100%              100%      99%
  16--19             467     39                                                   100%              100%              100%      100%
  20--24             476     30                                                   76.9%             100%              100%      98%
  25--30             487     19                                                   48%               100%              100%      95.8%

**Note:**

Refers to the number on transvaginal sonography, on which the lesions were seen.

**Abbreviation:** N, number.

###### 

Sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) of transvaginal sonography compared with sonohysterography

  **Day of cycle**   **Sensitivity**   **Specificity**   **PPV**   **NPV**
  ------------------ ----------------- ----------------- --------- ---------
  1--4               26.8%             98%               84.6%     80%
  5--8               39%               98%               88.8%     82.7%
  9--12              63%               98%               92.8%     88.8%
  13--15             85.3%             98%               94.5%     95.2%
  16--19             95%               98%               95%       98.2%
  20--24             73.1%             98%               93.7%     91.6%
  25--30             46.3%             98%               90.4%     84.5%

###### 

Sensitivity, specificity, positive predictive values (PPVs), and negative predictive values (NPVs) of transvaginal sonography (TVS) in different studies (complementary to [Figure 1](#f1-ijwh-3-353){ref-type="fig"}[\*](#tfn5-ijwh-3-353){ref-type="table-fn"})

  **Study**                                **Time TVS performed**                   **Sensitivity**   **Specificity**   **PPV**   **NPV**
  ---------------------------------------- ---------------------------------------- ----------------- ----------------- --------- ---------
  1\. Shalev and Dicker[@b13-ijwh-3-353]   Day 9--13                                100%              96.3%             91.3%     100%
  2\. Dueholm et al[@b22-ijwh-3-353]       Without relationship to phase of cycle   69%               83%               71%       82%
  3\. Guven et al[@b20-ijwh-3-353]         Without relationship to phase of cycle   78%               38%               61%       59%
  4\. Alborzi et al[@b19-ijwh-3-353]       Without relationship to phase of cycle   72%               92%               94%       65%
  5\. Kelekci et al[@b21-ijwh-3-353]       Early proliferative phase                56.2%             72%               56.3%     72%
  6\. Loverro et al[@b15-ijwh-3-353]       Day 6--10                                84.5%             98.7%             98%       89.2%
  7\. Valentin[@b23-ijwh-3-353]            Without relationship to phase of cycle   69%               83%               71%       82%
  8\. Grimbizis et al[@b24-ijwh-3-353]     Without relationship to phase of cycle   44.8%             77.5%             --        --
  9\. Present study                        Day 16--19                               95%               98%               95.1%     98%
  10\. Shalev et al[@b25-ijwh-3-353]       Follicular phase                         71.4%             100%              100%      97.1%

**Note:**

Studies 1--10 correlate with rows 1--10 in [Figure 1](#f1-ijwh-3-353){ref-type="fig"}.
